TNFSF13B and stage 5 chronic kidney disease: CYC: Cyclophosphamide; GPA: granulomatosis with polyangiitis; MPA: Microscopic polyangiitis; EGPA: Eosinophilic granulomatosis with polyangiitis; AAV: ANCA-associated vasculitis; C4aR: C5a receptor; GCs: Glucocorticoids; ESRD: End-stage renal disease; BAFF: B cell-activating factor; BLyS: B lymphocyte stimulator; IV: Intravenous